246 related articles for article (PubMed ID: 20874040)
1. Systemic preexposure prophylaxis for human immunodeficiency virus infection.
Romanelli F; Murphy B
Pharmacotherapy; 2010 Oct; 30(10):1021-30. PubMed ID: 20874040
[TBL] [Abstract][Full Text] [Related]
2. HIV exposure through contact with body fluids.
Prescrire Int; 2012 Apr; 21(126):100-1, 103-5. PubMed ID: 22515138
[TBL] [Abstract][Full Text] [Related]
3. HIV-serodiscordant couples desiring a child: 'treatment as prevention,' preexposure prophylaxis, or medically assisted procreation?
Mabileau G; Schwarzinger M; Flores J; Patrat C; Luton D; Epelboin S; Mandelbrot L; Matheron S; Yazdanpanah Y
Am J Obstet Gynecol; 2015 Sep; 213(3):341.e1-12. PubMed ID: 25979615
[TBL] [Abstract][Full Text] [Related]
4. Intracellular pharmacology of emtricitabine and tenofovir.
Stevens RC; Blum MR; Rousseau FS; Kearney BP
Clin Infect Dis; 2004 Sep; 39(6):877-8; author reply 878-9. PubMed ID: 15472830
[No Abstract] [Full Text] [Related]
5. Interim guidance for clinicians considering the use of preexposure prophylaxis for the prevention of HIV infection in heterosexually active adults.
Centers for Disease Control and Prevention (CDC)
MMWR Morb Mortal Wkly Rep; 2012 Aug; 61(31):586-9. PubMed ID: 22874836
[TBL] [Abstract][Full Text] [Related]
6. Chemoprophylaxis with tenofovir disoproxil fumarate provided partial protection against infection with simian human immunodeficiency virus in macaques given multiple virus challenges.
Subbarao S; Otten RA; Ramos A; Kim C; Jackson E; Monsour M; Adams DR; Bashirian S; Johnson J; Soriano V; Rendon A; Hudgens MG; Butera S; Janssen R; Paxton L; Greenberg AE; Folks TM
J Infect Dis; 2006 Oct; 194(7):904-11. PubMed ID: 16960777
[TBL] [Abstract][Full Text] [Related]
7. Intermittent prophylaxis with oral truvada protects macaques from rectal SHIV infection.
García-Lerma JG; Cong ME; Mitchell J; Youngpairoj AS; Zheng Q; Masciotra S; Martin A; Kuklenyik Z; Holder A; Lipscomb J; Pau CP; Barr JR; Hanson DL; Otten R; Paxton L; Folks TM; Heneine W
Sci Transl Med; 2010 Jan; 2(14):14ra4. PubMed ID: 20371467
[TBL] [Abstract][Full Text] [Related]
8. [HIV preexposure prophylaxis].
Olczak A; Grabczewska E
Przegl Epidemiol; 2012; 66(1):79-82. PubMed ID: 22708303
[TBL] [Abstract][Full Text] [Related]
9. Considerations regarding antiretroviral chemoprophylaxis in MSM.
Poynten IM; Zablotska I; Grulich AE
Curr Opin HIV AIDS; 2012 Nov; 7(6):549-56. PubMed ID: 22918448
[TBL] [Abstract][Full Text] [Related]
10. Prophylaxis of HIV infection.
Omrani AS; Freedman A
Br Med Bull; 2005; 73-74():93-105. PubMed ID: 16207801
[TBL] [Abstract][Full Text] [Related]
11. The risk of HIV drug resistance following implementation of pre-exposure prophylaxis.
van de Vijver DA; Boucher CA
Curr Opin Infect Dis; 2010 Dec; 23(6):621-7. PubMed ID: 20847692
[TBL] [Abstract][Full Text] [Related]
12. Genotypic resistance tests for the management of the HIV-infected pregnant woman.
Bassetti D; Cargnel A
Scand J Infect Dis Suppl; 2003; 106():70-4. PubMed ID: 15000589
[TBL] [Abstract][Full Text] [Related]
13. Molecular biological assessment methods and understanding the course of the HIV infection.
Katzenstein TL
APMIS Suppl; 2003; (114):1-37. PubMed ID: 14626050
[TBL] [Abstract][Full Text] [Related]
14. Abbreviated regimens of zidovudine prophylaxis and perinatal transmission of the human immunodeficiency virus.
Wade NA; Birkhead GS; Warren BL; Charbonneau TT; French PT; Wang L; Baum JB; Tesoriero JM; Savicki R
N Engl J Med; 1998 Nov; 339(20):1409-14. PubMed ID: 9811915
[TBL] [Abstract][Full Text] [Related]
15. Perinatally acquired HIV-1 infection: prevention and evaluation of HIV-exposed infants.
Shetty AK
Semin Pediatr Infect Dis; 2005 Oct; 16(4):282-95. PubMed ID: 16210108
[TBL] [Abstract][Full Text] [Related]
16. Strategies for prevention of perinatal transmission of HIV infection. Siena Consensus Workshop II.
J Acquir Immune Defic Syndr Hum Retrovirol; 1995 Feb; 8(2):161-75. PubMed ID: 7530586
[TBL] [Abstract][Full Text] [Related]
17. Study of the impact of HIV genotypic drug resistance testing on therapy efficacy.
Van Vaerenbergh K
Verh K Acad Geneeskd Belg; 2001; 63(5):447-73. PubMed ID: 11813503
[TBL] [Abstract][Full Text] [Related]
18. Emtricitabine + tenofovir to prevent HIV transmission. More evaluation needed.
Prescrire Int; 2013 Jul; 22(140):178-81. PubMed ID: 23951592
[TBL] [Abstract][Full Text] [Related]
19. Pre-exposure prophylaxis (PrEP) in HIV-uninfected individuals with high-risk behaviour.
Nadery S; Geerlings SE
Neth J Med; 2013; 71(6):295-9. PubMed ID: 23956310
[TBL] [Abstract][Full Text] [Related]
20. Reducing perinatal HIV transmission in developing countries through antenatal and delivery care, and breastfeeding: supporting infant survival by supporting women's survival.
Berer M
Bull World Health Organ; 1999; 77(11):871-7. PubMed ID: 10612882
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
